Lymphoseek approved to help locate lymph nodes
(HealthDay)—The injected imaging drug Lymphoseek (technetium Tc 99m tilmanocept) has been approved by the U.S. Food and Drug Administration to help surgeons locate the lymph nodes among people with breast cancer or melanoma.
Cancer
Mar 13, 2013 |
not rated yet |
0
BRAF inhibitor treatment causes melanoma cells to shift how they produce energy
A multi-institutional study has revealed that BRAF-positive metastatic malignant melanomas develop resistance to treatment with drugs targeting the BRAF/MEK growth pathway through a major change in metabolism. The findings, ...
Cancer
Mar 08, 2013 |
5 / 5 (3) |
0
|
Hope in stopping melanoma from spreading: Study shows that inhibiting key protein prevents metastasis to lungs in mice
(Medical Xpress)—Researchers have identified a critical protein role in the metastasis of melanoma, the most serious form of skin cancer. Inhibition of the protein known as adenosine diphosphate ribosylation ...
Cancer
Mar 05, 2013 |
5 / 5 (1) |
0
|
Tumors deliberately create conditions that inhibit body's best immune response
New research in the Journal of Clinical Investigation reveals that tumours in melanoma patients deliberately create conditions that knock out the body's 'premier' immune defence and instead attract a weaker immune respon ...
Cancer
Mar 01, 2013 |
5 / 5 (2) |
0
|
Adding elesclomol to paclitaxel for advanced melanoma studied
(HealthDay)—Lactate dehydrogenase (LDH) levels may be predictive of success in treating chemotherapy-naive patients with advanced melanoma with a combination of elesclomol plus paclitaxel, according to ...
Cancer
Feb 22, 2013 |
not rated yet |
0
Sunbed users are twice as likely to use anti-ageing products as non-sunbed users
Over two fifths (43 per cent) of people in the UK who have used sunbeds – which are proven to prematurely age the skin – are using anti-ageing products. This compares with only a fifth (20 per cent) ...
Cancer
Feb 21, 2013 |
not rated yet |
0
Gene identified in some melanoma linked to increased resistance to treatment
(Medical Xpress)—Scientists at Queen Mary, University of London have identified a gene present in some melanoma which appears to make the tumour cells more resistant to treatment, according to research ...
Cancer
Feb 19, 2013 |
5 / 5 (1) |
0
|
Early results show two drugs may be better than one to treat most deadly skin cancer
Adding lung cancer drugs to targeted melanoma treatment could increase survival for certain patients, according to research published in Cancer Discovery today.
Cancer
Feb 12, 2013 |
not rated yet |
0
|
Steroids help reverse rapid bone loss tied to rib fractures
New research in animals triggered by a combination of serendipity and counterintuitive thinking could point the way to treating fractures caused by rapid bone loss in people, including patients with metastatic ...
Medical research
Feb 05, 2013 |
5 / 5 (1) |
0
|
Immune system can use melanoma's own proteins to kill off cancer cells
Though a small group of proteins, the family called Ras controls a large number of cellular functions, including cell growth, differentiation, and survival. And because the protein has a hand in cellular division, mutated ...
Cancer
Feb 04, 2013 |
not rated yet |
0
|
Study reveals two-fold higher incidence of non-melanoma skin cancers for HIV patients
HIV-positive patients have a higher incidence of non-melanoma skin cancers, according to a Kaiser Permanente study that appears in the current online issue of the Journal of the National Cancer Institute. Specifically, basal ...
Cancer
Jan 29, 2013 |
5 / 5 (1) |
0
|
New mutations driving malignant melanoma discovered
Two new mutations that collectively occur in 71 percent of malignant melanoma tumors have been discovered in what scientists call the "dark matter" of the cancer genome, where cancer-related mutations haven't ...
Cancer
Jan 24, 2013 |
not rated yet |
0
|
Drug-resistant melanoma tumors shrink when therapy is interrupted
Researchers in California and Switzerland have discovered that melanomas that develop resistance to the anti-cancer drug vemurafenib (marketed as Zelboraf), also develop addiction to the drug, an observation ...
Cancer
Jan 09, 2013 |
3.7 / 5 (3) |
0
|
BMJ raises concerns over the effectiveness of a costly and invasive procedure for melanoma
A special report published by the BMJ today finds that thousands of melanoma patients around the world are undergoing an expensive and invasive procedure called sentinel node biopsy, despite a lack of clear evidence and co ...
Cancer
Jan 08, 2013 |
5 / 5 (1) |
0
Indication of considerable added benefit of vemurafenib in advanced melanoma
Vemurafenib has been approved since February 2012 for the treatment of certain groups of adults with advanced melanoma. The drug offers major advantages in terms of survival, but also causes major side effects. Overall, there ...
Cancer
Jan 08, 2013 |
not rated yet |
0
